fenoldopam has been researched along with sk&f-38393 in 158 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (17.09) | 18.7374 |
1990's | 129 (81.65) | 18.2507 |
2000's | 1 (0.63) | 29.6817 |
2010's | 1 (0.63) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brush, CK; Hahn, RA; Holden, KG; Kuo, GY; Ladd, DL; Pfeiffer, FR; Ridley, PT; Sarau, HM; Setler, PE; Tobia, AJ; Wardell, JR; Weinstock, J; Wilson, JW; Yim, NC | 1 |
Caron, MG; Tiberi, M | 1 |
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
Brooks, DP; Koster, PF; Nichols, AJ; Ruffolo, RR | 1 |
Jaffe, RS; Kien, ND; Moore, PG | 1 |
Gretler, DD; Jones, KC; Murphy, MB | 1 |
Ball, SG; Balmforth, AJ; Bryson, SE; Drew, GM; Hall, AS | 1 |
Griffin, B; Hackman, BB; Mills, M; Ramanathan, KB | 1 |
Cohen, HT; Katz, AI; Satoh, T | 1 |
Boppana, VK; Cyronak, MJ; Geschwindt, L; Rhodes, G | 1 |
Miledi, R; Panicker, MM; Woodward, RM | 1 |
Audet, P; Dafoe, D; Hedrich, D; Ilson, B; Jorkasky, DK; Shusterman, N; Stote, RM | 1 |
Brooks, DP; Gellai, M; Wang, YX | 1 |
Chen, CJ; Lokhandwala, MF | 1 |
Jadhav, AL; Liu, Q | 1 |
Bravette, B; Maroko, AR; Maroko, PR; Shi, Y; Zalewski, A | 1 |
Olson, MF; Schimmer, BP | 1 |
Carruba, MO; Memo, M; Nisoli, E; Pizzi, M; Reina, G; Spano, P; Tonello, C | 1 |
Grenader, A; Healy, DP | 2 |
Drummond, WH; Kennedy, LA; Polak, MJ | 1 |
Cohen, HT; Katz, AI; Satoh, T; Takemoto, F | 1 |
Guillery, EN; Jose, PA; Robillard, JE; Segar, JL; Smith, FG | 1 |
Childers, RW; Elliott, WJ; Gretler, DD; Moscucci, M; Murphy, MB | 1 |
Christie, MI; Harper, D; Smith, GW | 1 |
Albrecht, FE; Eisner, GM; Felder, RA; Horiuchi, A; Jose, PA | 1 |
Brooderson, RJ; Wachtel, SR; White, FJ | 1 |
Bacq, Y; Braillon, A; Gaudin, C; Hadengue, A; Lebrec, D; Moreau, R | 1 |
Agner, T; Boesgaard, S; Hagen, C; Nyboe Andersen, A | 1 |
Andersen, AN; Boesgaard, S; Eldrup, E; Hagen, C; Hangaard, J | 2 |
Apparsundaram, S; Chen, CJ; Lokhandwala, MF | 1 |
Cavero, I; Lawson, K; Le Monnier de Gouville, AC; Thiry, C | 1 |
Elliott, WJ; Geanon, J; Karnezis, TA; Murphy, MB; Silverman, RA; Tripathi, RC | 1 |
Blanchett, DG; Boyle, DA; Corder, CN; Cyronak, MJ; Green, JA; Jarvis, RC; Kasmer, RJ; Nara, A; Pospisil, R | 1 |
Baxter, GM; Moore, JN; Tackett, RL | 1 |
Brooks, DP; Mitchell, MP; Nichols, AJ; Ruffolo, RR; Short, BG | 1 |
Freestone, S; Jeffrey, RF; Lee, MR; MacDonald, TM | 1 |
Stanford, GG | 1 |
Aronson, S; Glock, D; Goldberg, LI; Moss, J; Roizen, MF; Roth, S | 2 |
Horn, PT; Kohli, JD | 1 |
Guenaneche, F; Lefebvre, RA; Schuurkes, JA | 1 |
Felder, RA; Ohbu, K | 1 |
Forgione, A; Missale, C; Rizzonelli, P; Sigala, S; Spano, P; Zanelli, E | 1 |
Girbes, AR; Smit, AJ; van Veldhuisen, DJ | 1 |
Bass, AS; Murphy, MB | 1 |
Clark, KL; Drew, GM; Hilditch, A; Robertson, MJ | 1 |
Den Boer, MO; Duncker, DJ; McFalls, EO; Sassen, LM; Saxena, PR; Van Woerkens, LJ; Verdouw, PD | 1 |
Clas, DM; Ezrin, AM; Gorczyca, WP; Lee, KC; Silver, PJ | 1 |
Evans, AM; Green, KL | 1 |
Häberle, DA; Königbauer, B | 1 |
Cheng, L; Frank, D; Liang, CT; Precht, P | 1 |
Cestari, R; Lojacono, L; Memo, M; Missale, C; Missale, G; Sigala, S; Spano, P | 1 |
Clark, KL; Drew, GM; Robertson, MJ | 1 |
Barthelmebs, M; Froehly, S; Grima, M; Imbs, JL; Stephan, D; Vailly, B; Velly, J | 1 |
Demenge, P; Pellissier, G | 1 |
Elliott, WJ; Murphy, MB | 1 |
Benotti, JR; Green, JA; Jarvis, RC; Kasmer, RJ; McCue, JE; Munger, MA; Nara, AR; Pospisil, RA | 1 |
Glover, J; Polson, RJ; Settin, A; Vlavianos, P; Westaby, D; Williams, R | 1 |
Gonzalez, FM; Huth, MM; Nguyen, BP; Reisin, E; Weed, SG | 1 |
Andersen, AN; Boesgaard, S; Eldrup, E; Fenger, M; Hagen, C | 1 |
Elliott, WJ; Fumo, MT; Gretler, DD; McCray, GR; Murphy, MB; Nelson, KS; Oliner, CM; Weber, RR | 1 |
Carruba, MO; Memo, M; Missale, C; Nisoli, E; Spano, PF | 1 |
Arendshorst, WJ; Pollock, DM | 1 |
Girbes, AR; Meijer, S; Reitsma, WD; Smit, AJ | 3 |
Anderson, L; Bednarczyk, EM; Emmanuel, G; Gonzalez, FM; Green, JA; Hakki, AI; Munger, MA; Panacek, EA; Rutherford, WF; Weed, SG | 1 |
Jeffrey, RF; Lee, MR; MacDonald, TM; Muir, AL | 1 |
Carey, RM; Chevalier, RL; Felder, RA; Lynd, M; Peach, MJ; Ragsdale, NV | 1 |
Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A | 1 |
Kecskeméti, V; Kertész, Z | 1 |
Antonipillai, I; Bughi, S; Horton, R; Jost-Vu, E; Nadler, J | 1 |
Brooks, DP; Nichols, AJ; Ruffolo, RR | 1 |
Beck, TR; Holcslaw, TL | 1 |
Carey, RM; Chevalier, RL; Felder, RA; Howell, NL; Peach, MJ; Ragsdale, NV; Siragy, HM | 1 |
Hegde, SS; Lokhandwala, MF | 1 |
Felder, RA; Kaskel, FJ; Kinoshita, S; Ohbu, K; Sidhu, A | 1 |
Brooks, DP; Drutz, DJ; Ruffolo, RR | 1 |
Albrecht, F; Campbell, T; Felder, CC; Jose, PA | 1 |
Brooks, DP; Bryant, MA; Chambers, PA; Cyronak, MJ; DePalma, PD; Erhard, KF; Gaitanopoulos, DE; Karpinski, K; Mico, B; Weinstock, J | 1 |
Comans, EF; de Fijter, CW; de Vries, PM; Donker, AJ; Oe, PL; Roos, JC; Smit, AJ; Streurman, O | 1 |
Brooks, DP; DePalma, PD; DiCristo, M; Goldstein, R; Hyneck, M; Karpinski, K; Koster, PF | 1 |
Aperia, A; Bertorello, AM; Greengard, P; Hopfield, JF | 1 |
Bajwa, SB; Mishra, RK; Ross, GM; Srivastava, LK | 1 |
De Beurme, FA; Guenaneche, F; Lefebvre, RA | 1 |
Buchholz, RA; Dundore, RL; Hallenbeck, WD; Pratt, PF; Silver, PJ; Wassey, ML | 1 |
Dupont, AG; Schoors, DF | 2 |
Horner, E; Kinter, LB; Mann, WA; Ruffolo, RR; Weinstock, J | 1 |
Brooks, DP; Cyronak, MJ; DePalma, PD; Karpinski, K; Weinstock, J | 1 |
Hegde, SS; Lokhandwala, MF; Vyas, SJ | 1 |
Felder, RA; VanCampen, M | 1 |
Casagrande, C; La Regina, A; Merlo, L | 1 |
Hughes, AD; Sever, PS | 1 |
Kopia, GA; Valocik, RE | 1 |
Weiss, B; Winkler, JD | 1 |
Bucciarelli, RL; Drummond, W; Gause, GE; Knight, ME; Polak, MJ | 1 |
Bazzett, TJ; Eaton, RC; Hull, EM; Scaletta, LL; Thompson, JT; Warner, RK | 1 |
Boppana, VK; Cyronak, MJ; Stote, RM; Ziemniak, JA | 1 |
Aperia, A; Cortés, R; Ehrlich, M; Fryckstedt, J; Greengard, P; Hemmings, HC; Hökfelt, T; Meister, B; Nairn, AC; Schalling, M | 1 |
Hasenfuss, G; Just, H | 1 |
Antonipillai, I; Bughi, S; Ehrlich, L; Horton, R; Manoogian, C; Nadler, J | 1 |
Andersen, AN; Boesgaard, S; Eldrup, E; Hagen, C; Lange, P | 1 |
Felder, RA; Kinoshita, S; Sidhu, A | 1 |
Bordi, F; Meller, E | 1 |
Ambrosioni, E; Fuccella, LM; Malini, PL; Pasinelli, F; Riva, E; Strocchi, E; Tartagni, F; Valtancoli, G | 1 |
Amenta, F; Hedge, SS; Lokhandwala, MF; Ricci, A | 1 |
Clark, ES; Moore, JN | 1 |
Cooper, SJ; Rusk, IN | 1 |
Alcázar, JM; Alvarez, C; Andrés, A; García-Robles, R; Martínez, J; Oliet, A; Rodicio, JL; Ruilope, LM; Sancho, J | 1 |
Beart, PM; Cincotta, M; de Vries, DJ | 1 |
Crooke, ST; Flaim, KE; Gessner, GW; Heys, JR; Weinstock, J | 1 |
Edwards, RM | 1 |
Beninger, RJ; Hoffman, DC | 1 |
Goldberg, LI | 1 |
Burland, WL; Cregeen, RJ; Mills, JG; Rudge, PJ; Vincent, SH | 1 |
Hasan, S; Hughes, AD; Redman, D; Sever, PS; Thom, SA | 1 |
Creese, I; Leff, SE; Sibley, DR | 1 |
Alam, AM; Starr, MS | 1 |
Andres, A; Martinez, J; Robles, RG; Ruilope, LM; Sancho, JM; Villa, E | 1 |
Aperia, A; Eklöf, AC; Greengard, P; Ibarra, F; Svensson, LB | 1 |
Thompson, LA; Twery, MJ; Walters, JR | 1 |
Katz, JL; Newman, AH; Nowak, G; Witkin, JM | 1 |
Dawson, R; Felheim, R; Phillips, MI | 1 |
Arendshorst, WJ; Chatziantoniou, C; Ruan, X | 1 |
Brooks, DP; Wang, YX | 1 |
Christie, MI; Smith, GW | 1 |
Aperia, A; Fryckstedt, J; Lindén, M; Svensson, LB | 1 |
Bodmann, KF; Clemens, R; Schuster, HP; Tröster, S | 1 |
Cestari, R; Lojacono, L; Missale, C; Missale, G; Raddino, R; Sigala, S; Spano, PF | 1 |
Polak, MJ; Taylor, DA | 1 |
Giambalvo, CT; Wagner, RL | 1 |
Friedman, E; Undie, AS | 1 |
Anderson, JJ; Chase, TN; Engber, TM; Kuo, S | 1 |
Jacinto, SM; Jandhyala, BS | 1 |
Kinter, LB; Mann, WA; Ruffolo, RR; Weinstock, J | 1 |
Hennes, HJ; Jantzen, JP | 1 |
Eades, SC; Moore, JN | 1 |
Frankenschmidt, A; Rump, LC; Schaible, U; Schollmeyer, PJ; Schuster, MJ; Schwertfeger, E | 1 |
Drummond, WH; Polak, MJ | 1 |
Felder, RA; Hendley, ED; Ohbu, K; Yamaguchi, I | 1 |
Chen, C; Lokhandwala, MF | 1 |
Berenguer, A; Estañ, L; Martinez-Mir, I; Morales-Olivas, FJ; Rubio, E | 1 |
de Vaal, JB; Mitha, AS; Patel, JJ; Sareli, P | 1 |
Aperia, A; Bertorello, AM; Eklöf, AC; Nishi, A | 1 |
Feneck, RO; Hill, AJ; Walesby, RK | 1 |
Albrecht, FE; Campbell, T; Eisner, GM; Felder, CC; Jose, PA | 1 |
Brooks, DP; DePalma, D | 1 |
Elliott, WJ; Shusterman, NH; White, WB | 1 |
Elliot, WJ; Green, JA; Murphy, MB; Nara, AR; Panacek, EA; Pilmer, BL; Rutherford, W | 1 |
Favre, H; Poinsot, O; Romand, JA; Suter, PM | 1 |
Asico, LD; Jose, PA; Li, XX; Xu, J; Yao, LP; Yu, PY | 1 |
Brusniak, MY; Neve, KA; Pearlman, RS; Wilcox, RE | 1 |
Brusniak, MY; DuRand, C; Ginsburg, B; Neve, KA; Pearlman, RS; Starr, S; Teeter, M; Tseng, T; Wilcox, RE | 1 |
9 review(s) available for fenoldopam and sk&f-38393
Article | Year |
---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
Use of inotropic agents in critical illness.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cardiac Output; Cardiotonic Agents; Catecholamines; Critical Care; Dopamine; Fenoldopam; Humans; Imidazoles; Ketanserin; Oxygen; Phosphodiesterase Inhibitors; Quinolines; Vasodilator Agents | 1991 |
Dopamine and dopamine receptor agonists in cardiovascular therapy.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Biological Availability; Blood Pressure; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Heart Failure; Humans; Hypertension; Receptors, Dopamine; Receptors, Dopamine D2; Shock | 1990 |
The pharmacology of fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenergic alpha-Antagonists; Animals; Chemical Phenomena; Chemistry; Dopamine Agents; Endothelium, Vascular; Enzyme Activation; Fenoldopam; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Splenic Artery; Vasodilation | 1990 |
Clinical experience with intravenous fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cardiovascular System; Chemical Phenomena; Chemistry; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Injections, Intravenous; Kidney; Receptors, Dopamine; Receptors, Dopamine D1; Reference Values | 1990 |
Dopamine-1 and dopamine-2 mechanisms in the control of renal function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Biomechanical Phenomena; Dopamine; Dopamine Agents; Fenoldopam; Humans; Kidney; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1990 |
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
Dopamine and new dopamine analogs: receptors and clinical applications.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Dopamine; Dopamine Agents; Fenoldopam; Humans; Receptors, Adrenergic; Receptors, Dopamine; Vasodilator Agents | 1988 |
23 trial(s) available for fenoldopam and sk&f-38393
Article | Year |
---|---|
Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Analysis of Variance; Blood Pressure; Chi-Square Distribution; Female; Fenoldopam; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Radionuclide Ventriculography; Vasodilator Agents; Ventricular Function, Left | 1992 |
Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Adult; Cyclosporine; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Renal Circulation; Vasoconstriction | 1992 |
Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. SK&F Fenoldopam Working Group.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Fenoldopam; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Nitroprusside; Vasodilator Agents | 1992 |
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acute Disease; Adult; Dopamine Agents; Electrocardiography; Emergencies; Female; Fenoldopam; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Prospective Studies; Vasodilator Agents | 1992 |
Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Corticotropin-Releasing Hormone; Dopamine Agents; Estradiol; Female; Fenoldopam; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infusions, Intravenous; Luteinizing Hormone; Prolactin; Receptors, Dopamine; Receptors, Dopamine D1; Reference Values; Thyrotropin-Releasing Hormone; Time Factors | 1991 |
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Blood Pressure; Dose-Response Relationship, Drug; Epinephrine; Female; Fenoldopam; Heart Rate; Humans; Hypertension; Intraocular Pressure; Male; Middle Aged; Nitroprusside; Norepinephrine; Vasodilator Agents | 1991 |
The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Adult; Aged; Biological Availability; Female; Fenoldopam; Food; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Random Allocation; Vasodilator Agents | 1991 |
A single dose study of the effects of fenoldopam and enalapril in mild hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Blood Pressure; Creatinine; Dopamine Agents; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enalapril; Fenoldopam; Humans; Hypertension; Middle Aged; Natriuresis; Posture; Pulse | 1991 |
Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Blood Pressure; Blood Urea Nitrogen; Creatine; Fenoldopam; Ferricyanides; Heart Rate; Humans; Hypertension; Injections, Intravenous; Middle Aged; Nitroprusside; Randomized Controlled Trials as Topic | 1990 |
Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenocorticotropic Hormone; Adult; Dopamine; Female; Fenoldopam; Glucose; Humans; Hydrocortisone; Infusions, Intravenous; Male; Metoclopramide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1990 |
A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aged; Body Weight; Coronary Disease; Dopamine Agents; Double-Blind Method; Exercise Test; Fenoldopam; Heart Failure; Heart Ventricles; Humans; Middle Aged; Radionuclide Ventriculography; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 1990 |
Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Dopamine; Dopamine Agents; Female; Fenoldopam; Humans; Receptors, Dopamine; Secretory Rate; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Dopamine Agents; Fenoldopam; Hemodynamics; Humans; Kidney; Male; Metabolism; Receptors, Dopamine; Receptors, Dopamine D1; Reference Values; Renal Circulation; Renin; Sodium | 1990 |
Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adolescent; Adult; Aldosterone; Blood Pressure; Calcium; Catecholamines; Dopamine Agents; Endocrine Glands; Female; Fenoldopam; Glomerular Filtration Rate; Heart Rate; Humans; Kidney; Male; Metoclopramide; Middle Aged; Natriuresis; Renal Circulation; Renin | 1990 |
Lithium and the renal response to gludopa, fenoldopam and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Drug Interactions; Fenoldopam; Humans; Kidney Tubules, Proximal; Lithium; Natriuresis; Receptors, Dopamine | 1990 |
Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Dopamine Agents; Fenoldopam; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Pituitary Hormones; Prolactin; Testosterone; Thyroid Hormones; Thyrotropin; Time Factors | 1989 |
Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Dopamine Agents; Double-Blind Method; Fenoldopam; Heart Rate; Hemodynamics; Humans; Male | 1985 |
Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Diuresis; Dopamine Agents; Female; Fenoldopam; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Vascular Resistance | 1993 |
Intravenous fenoldopam infusion in severe heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Diuretics; Dopamine Agents; Dose-Response Relationship, Drug; Female; Fenoldopam; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Male; Natriuresis; Vasodilator Agents | 1993 |
A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Atrial Function, Right; Blood Pressure; Cardiac Output; Coronary Artery Bypass; Creatinine; Dopamine Agents; Female; Fenoldopam; Heart Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Nitroprusside; Potassium; Pulmonary Artery; Pulmonary Wedge Pressure; Sodium; Stroke Volume; Vascular Resistance | 1993 |
Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Creatinine; Female; Fenoldopam; Hemodynamics; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Nitroprusside; Renal Insufficiency; Severity of Illness Index; Vasodilator Agents | 1993 |
Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Blood Pressure; Female; Fenoldopam; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Single-Blind Method | 1993 |
Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Dopamine Agents; Dose-Response Relationship, Drug; Female; Fenoldopam; Forced Expiratory Flow Rates; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Positive-Pressure Respiration; Renal Circulation; Urine | 1993 |
126 other study(ies) available for fenoldopam and sk&f-38393
Article | Year |
---|---|
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
Topics: Animals; Benzazepines; Central Nervous System; Kidney; Rats; Receptors, Dopamine; Structure-Activity Relationship; Vasodilator Agents | 1980 |
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Brain; Butaclamol; Cell Line; Cell Membrane; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Fenoldopam; Flupenthixol; Genomic Library; GTP-Binding Proteins; Humans; Kidney; Kinetics; Rats; Receptors, Dopamine D1; Transfection | 1994 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphotericin B; Animals; Creatinine; Dogs; Dopamine Agents; Female; Fenoldopam; Kidney Diseases; Male; Receptors, Dopamine; Renal Circulation | 1992 |
Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia, Inhalation; Animals; Dogs; Female; Fenoldopam; Halothane; Heart; Hemodynamics; Hypotension; Male; Nitroprusside; Regional Blood Flow; Vasodilator Agents | 1992 |
5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Atropine; Benzazepines; Dogs; Dopamine Agents; Drug Interactions; Fenoldopam; In Vitro Techniques; Indomethacin; Ketanserin; Methysergide; Muscle, Smooth; Receptors, Serotonin; Serotonin; Trachea; Vasodilator Agents | 1992 |
Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Fenoldopam; Glomerular Mesangium; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Tetrahydronaphthalenes | 1992 |
Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arachidonic Acid; Corticosterone; Cyclic AMP; Dopamine; Fenoldopam; Kidney Cortex; Kidney Tubules, Collecting; Male; Phospholipases A; Phospholipases A2; Protein Kinase Inhibitors; Quinacrine; Rats; Rats, Inbred Strains; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 1992 |
Determination of the enantiomers of fenoldopam in human plasma by reversed-phase high-performance liquid chromatography after chiral derivatization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Chromatography, High Pressure Liquid; Fenoldopam; Humans; Male; Stereoisomerism; Vasodilator Agents | 1992 |
Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catecholamines; Cloning, Molecular; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Female; Fenoldopam; In Vitro Techniques; Kinetics; Membrane Potentials; Oocytes; Quinpirole; Receptors, Serotonin; Salicylamides; Transcription, Genetic; Xenopus | 1992 |
Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Glycine; Male; Natriuresis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Renal Circulation; Time Factors; Vascular Resistance | 1992 |
An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Diuresis; Dopamine; Dopamine Agents; Fenoldopam; Hypertension; Kidney Tubules; Male; Natriuresis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1; Sodium Chloride | 1992 |
DA1 receptor mediated regulation of Na(+)-H+ antiport activity in rat renal cortical brush border membrane vesicles.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amiloride; Animals; Carrier Proteins; Dopamine; Dopamine Antagonists; Fenoldopam; In Vitro Techniques; Kidney Cortex; Kinetics; Male; Microvilli; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Sodium; Sodium-Hydrogen Exchangers | 1992 |
Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Constriction; Coronary Circulation; Coronary Disease; Dogs; Dopamine; Dopamine Agents; Fenoldopam; Hemodynamics; Renal Circulation; Stimulation, Chemical | 1992 |
Heterologous desensitization of the human dopamine D1 receptor in Y1 adrenal cells and in a desensitization-resistant Y1 mutant.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenal Cortex Neoplasms; Adrenergic beta-Agonists; Adrenocorticotropic Hormone; Animals; Dopamine; Dopamine Agents; Drug Tolerance; Enzyme Activation; Fenoldopam; Mice; Mutation; Receptors, Adrenergic, beta; Receptors, Dopamine; Signal Transduction; Sodium Fluoride; Tumor Cells, Cultured | 1992 |
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Analysis of Variance; Animals; Brain; Down-Regulation; Drug Tolerance; Ergolines; Fenoldopam; Lisuride; Male; Motor Activity; Quinpirole; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1992 |
A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Cells, Cultured; Chromans; Cyclic AMP; Dopamine; Dopamine Agents; Epithelial Cells; Epithelium; Fenoldopam; Kidney; Receptors, Dopamine D1 | 1992 |
Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Fenoldopam; Hypoxia; In Vitro Techniques; Lung; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Vasoconstriction; Vasodilator Agents | 1992 |
Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cell Line; Cyclic AMP; Dogs; Dopamine; Dopamine Agents; Ergolines; Fenoldopam; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Quinpirole; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 1992 |
Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arteries; Blood Pressure; Dopamine Agents; Female; Fenoldopam; Fetal Blood; Fetus; Heart Rate, Fetal; Hemodynamics; Kidney; Pregnancy; Receptors, Dopamine D1; Renal Circulation; Sheep | 1992 |
Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aorta; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; In Vitro Techniques; Ketanserin; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Vasoconstriction | 1992 |
Renal dopamine receptors and pre- and post-cAMP-mediated Na+ transport defect in spontaneously hypertensive rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Biological Transport; Carrier Proteins; Cyclic AMP; Dopamine Agents; Ethylmaleimide; Fenoldopam; Guanylyl Imidodiphosphate; Kidney; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Sodium; Sodium-Hydrogen Exchangers; Thionucleotides | 1992 |
Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Fenoldopam; Grooming; Male; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1992 |
Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Ascites; Dopamine Agents; Fenoldopam; Hemodynamics; Humans; Kidney; Liver Circulation; Liver Cirrhosis; Middle Aged; Norepinephrine; Receptors, Dopamine; Receptors, Dopamine D1; Renal Circulation; Splanchnic Circulation | 1991 |
Dopaminergic inhibition of glycoprotein hormone alpha-subunit in normal subjects.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Dopamine; Dopamine Agents; Fenoldopam; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Metoclopramide; Reference Values; Thyrotropin; Time Factors | 1991 |
Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Benzazepines; Captopril; Dopamine Agents; Fenoldopam; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Renin-Angiotensin System; Sodium | 1991 |
SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cardiovascular System; Dopamine Agents; Fenoldopam; Hemodynamics; Infusions, Intravenous; Injections, Intravenous; Male; Norepinephrine; Rats; Receptors, Dopamine; Receptors, Serotonin; Renin; Vasodilator Agents | 1991 |
In vitro responses of equine digital vessels to dopamine and fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arteries; Dopamine; Dose-Response Relationship, Drug; Fenoldopam; Forelimb; Hindlimb; Hoof and Claw; Horses; Norepinephrine; Prazosin; Vasoconstriction; Vasodilator Agents; Veins | 1991 |
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphotericin B; Animals; Benzazepines; Carbamates; Creatinine; Diuresis; Dogs; Fenoldopam; Kidney; Kidney Tubules; Male; Natriuresis; Prodrugs | 1991 |
Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cell Line; Cyclic AMP; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Receptors, Dopamine; Receptors, Dopamine D1 | 1991 |
Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia, Inhalation; Animals; Blood Pressure; Cardiac Output; Dogs; Dopamine Agents; Fenoldopam; Heart Rate; Isoflurane; Kidney; Male; Nitroprusside; Pulmonary Wedge Pressure; Renal Circulation; Vascular Resistance; Vasodilator Agents | 1991 |
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dogs; Dopamine; Dopamine Agents; Ergolines; Fenoldopam; Histamine Antagonists; Male; Quinpirole; Receptors, Dopamine; Renal Circulation; Sympatholytics; Synapses; Vasodilation | 1991 |
Influence of fenoldopam and quinpirole in the guinea-pig stomach.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clonidine; Dopamine; Dopamine Agents; Electric Stimulation; Ergolines; Female; Fenoldopam; Guinea Pigs; Haloperidol; In Vitro Techniques; Male; Methysergide; Muscle Contraction; Muscle Relaxation; Prazosin; Quinpirole; Stomach; Yohimbine | 1991 |
DA1 dopamine receptors in renal cortical collecting duct.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Arginine Vasopressin; Benzazepines; Binding, Competitive; Dopamine Agents; Dopamine Antagonists; Fenoldopam; Iodine Radioisotopes; Kidney Cortex; Kidney Tubules, Collecting; Kinetics; Male; Radioligand Assay; Rats; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1 | 1991 |
Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Binding Sites; Bromocriptine; Corpus Striatum; Dopamine; Down-Regulation; Fenoldopam; Frontal Lobe; Male; Norepinephrine; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Dopamine; Sulpiride | 1991 |
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic | 1991 |
Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine; Dopamine Agents; Dopamine Antagonists; Extracellular Space; Fenoldopam; Isotonic Solutions; Male; Natriuresis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium Chloride | 1991 |
Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Captopril; Diuresis; Dogs; Dopamine Agents; Female; Fenoldopam; Kidney; Male; Peptidyl-Dipeptidase A; Receptors, Dopamine; Vasodilation | 1991 |
Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Dopamine; Dopamine Agents; Female; Fenoldopam; Heart; Heart Rate; Hemodynamics; Infusions, Intravenous; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Receptors, Dopamine; Receptors, Dopamine D1; Swine; Vascular Resistance | 1991 |
Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Pressure; Cardiotonic Agents; Diuretics; Dogs; Female; Fenoldopam; Heart Rate; Hydralazine; Male; Milrinone; Myocardial Contraction; Nitroprusside; Pyridazines; Pyridones; Vasodilator Agents | 1991 |
Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cockroaches; Dopamine Agents; Electrophysiology; Ergolines; Fenoldopam; In Vitro Techniques; Membrane Potentials; Quinolines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salivary Glands; Sulpiride | 1991 |
Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Feedback; Fenoldopam; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Male; Metoclopramide; Rats; Rats, Inbred Strains; Sodium, Dietary | 1991 |
Dopamine stimulation of cAMP production in cultured opossum kidney cells.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Cell Line; Cyclic AMP; Dopamine; Dopamine Agents; Fenoldopam; Isoproterenol; Kidney; Norepinephrine; Serotonin; Stimulation, Chemical | 1990 |
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adult; Benzazepines; Bromocriptine; Butaclamol; Dopamine Agents; Dose-Response Relationship, Drug; Esophagus; Fenoldopam; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Benzazepines; Cats; Diuresis; Domperidone; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Female; Fenoldopam; Hemodynamics; Kidney; Kidney Tubules; Male; Phentolamine; Receptors, Dopamine | 1991 |
Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Carbidopa; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Hemodynamics; Levodopa; Male; Prodrugs; Rats; Rats, Inbred Strains; Streptozocin | 1991 |
Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Blood Pressure; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fenoldopam; Heart Rate; Injections, Spinal; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Spinal Cord | 1991 |
Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Aged, 80 and over; Drug Tolerance; Female; Fenoldopam; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors; Vasodilator Agents | 1990 |
Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Cardiac Output; Dose-Response Relationship, Drug; Electrocardiography; Female; Fenoldopam; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Regional Blood Flow; Splanchnic Circulation; Vascular Resistance; Vasodilator Agents | 1990 |
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Fenoldopam; Ferricyanides; Hemodynamics; Humans; Hypertension; Hypertension, Malignant; Kidney; Kidney Function Tests; Male; Middle Aged; Nitroprusside | 1990 |
Repeated administration of lisuride down-regulates dopamine D-2 receptor function in mesostriatal and in mesolimbocortical rat brain regions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Down-Regulation; Ergolines; Fenoldopam; Hippocampus; Limbic System; Lisuride; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Pressure; Capillaries; Dopamine Agents; Feedback; Fenoldopam; Glomerular Filtration Rate; Homeostasis; Kidney Glomerulus; Kidney Tubules; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Renal Circulation; Vasodilation | 1990 |
Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dogs; Dopamine Agents; Fenoldopam; Hypotension, Controlled; Male; Renal Circulation; Vasodilator Agents | 1990 |
Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aldosterone; Dopamine Agents; Electrolytes; Female; Fenoldopam; Humans; Kidney; Lithium; Male; Middle Aged; Natriuresis; Receptors, Dopamine; Renin | 1990 |
Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Blood Pressure; Female; Fenoldopam; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Kidney; Male; Middle Aged; Vasodilator Agents | 1990 |
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains | 1990 |
Effect of fenoldopam on action potential characteristics in left atrial and right ventricular papillary fibers of guinea-pig.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Fenoldopam; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Papillary Muscles | 1990 |
Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Humans; Hypertension; Kidney; Male; Prostaglandins; Rats; Reference Values; Renal Circulation; Renin | 1990 |
Renal dopamine and sodium excretion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Diuresis; Domperidone; Dopamine; Fenoldopam; Isotonic Solutions; Kidney; Male; Natriuresis; Rats; Rats, Inbred Strains; Sodium Chloride | 1990 |
A renal dopamine-1 receptor defect in two genetic models of hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Aging; Animals; Dopamine Agents; Fenoldopam; Hypertension; Kidney; Kidney Tubules, Proximal; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1; Sodium Chloride | 1990 |
Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Body Weight; Cyclosporins; Fenoldopam; Injections, Intraperitoneal; Injections, Intravenous; Inulin; Kidney Diseases; Male; p-Aminohippuric Acid; Rats; Rats, Inbred Strains; Vascular Resistance; Vasodilator Agents | 1990 |
Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Carrier Proteins; Cyclic AMP; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Kidney; Kidney Cortex; Male; Microvilli; Osmolar Concentration; Rats; Rats, Inbred WKY; Sodium; Sodium-Hydrogen Exchangers; Time Factors | 1990 |
Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Animals; Benzazepines; Blood Pressure; Carbamates; Dogs; Dopamine Agents; Female; Fenoldopam; Heart Rate; Prodrugs; Renal Circulation; Vasodilator Agents | 1990 |
The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Adult; Aged; Aldosterone; Blood Pressure; Drug Evaluation; Female; Fenoldopam; Hemodynamics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Natriuresis; Renal Circulation; Sodium; Time Factors; Vasodilator Agents | 1990 |
Effect of fenoldopam in dogs with spontaneous renal insufficiency.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Animals; Creatinine; Dogs; Dopamine Agents; Female; Fenoldopam; Humans; In Vitro Techniques; Injections, Intravenous; Kidney Cortex; Kidney Failure, Chronic; Male; p-Aminohippuric Acid | 1990 |
Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine Triphosphate; Animals; Benserazide; Corpus Striatum; Dopamine; Dopamine Antagonists; Ergolines; Fenoldopam; Guinea Pigs; Kinetics; Neurons; Ouabain; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium-Potassium-Exchanging ATPase | 1990 |
Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding, Competitive; Cattle; Cell Membrane; Centrifugation, Density Gradient; Cholic Acid; Cholic Acids; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Fenoldopam; Guanylyl Imidodiphosphate; Liposomes; Receptors, Dopamine; Receptors, Dopamine D1; Solubility | 1990 |
Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Drug Interactions; Electric Stimulation; Ergolines; Female; Fenoldopam; Gastric Fundus; In Vitro Techniques; Male; Methacholine Compounds; Muscle Contraction; Muscle, Smooth; Quinpirole; Rats; Receptors, Dopamine; Receptors, Serotonin; Stomach; Vasodilator Agents | 1990 |
Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atrial Natriuretic Factor; Blood Pressure; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Fenoldopam; Male; Nitroprusside; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Rats; Rats, Inbred SHR | 1990 |
Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Drug Interactions; Fenoldopam; Humans; Kidney Tubules, Proximal; Lithium; Natriuresis; Receptors, Dopamine | 1990 |
Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Pressure; Bradykinin; Dogs; Domperidone; Dopamine; Dopamine Agents; Female; Fenoldopam; Heart Rate; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Male; Renal Circulation; Stereoisomerism; Structure-Activity Relationship; Vascular Resistance; Vasodilator Agents | 1990 |
Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Benzazepines; Biotransformation; Blood Pressure; Carbamates; Dogs; Female; Fenoldopam; Pentobarbital; Physostigmine; Prodrugs; Renal Circulation; Vascular Resistance; Vasodilator Agents | 1990 |
Renal dopamine and tubular DA-1 receptors in the regulation of sodium excretion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atrial Natriuretic Factor; Dopamine; Dopamine Agents; Fenoldopam; Kidney; Kidney Tubules; Male; Natriuresis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1990 |
Differential modulation of the renal proximal tubular DA-1 receptor by Gpp(NH)p and sodium in the spontaneously hypertensive rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine Agents; Fenoldopam; Guanylyl Imidodiphosphate; Hypertension; Kidney Tubules, Proximal; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1; Sodium | 1990 |
The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Aged, 80 and over; Arteries; Benzazepines; Butaclamol; Dopamine; Dopamine Agents; Female; Fenoldopam; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Omentum; Phentolamine; Regional Blood Flow; Skin; Sulpiride | 1989 |
Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Angina Pectoris; Animals; Benzazepines; Coronary Circulation; Dogs; Domperidone; Dopamine; Female; Fenoldopam; Male; Receptors, Dopamine; Receptors, Dopamine D1; Vasodilation | 1989 |
Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Ergolines; Fenoldopam; Indoles; Male; Mice; Phenanthridines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Tetrahydronaphthalenes; Thiophenes | 1989 |
Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dinoprost; Dopamine Agents; Dopamine Antagonists; Fenoldopam; In Vitro Techniques; Lung; Male; Perfusion; Pulmonary Circulation; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoconstriction | 1989 |
D2/D1 ratio in the medial preoptic area affects copulation of male rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Copulation; Female; Fenoldopam; Male; Preoptic Area; Quinolines; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
A retrospective analysis of fenoldopam renal excretion in 65 subjects: evidence for possible intrarenal formation of fenoldopam from its metabolites.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Dopamine Agents; Fenoldopam; Humans; Kidney; Retrospective Studies | 1989 |
Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antibodies, Monoclonal; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Fenoldopam; Fluorescent Antibody Technique; Kidney Tubules; Kinetics; Loop of Henle; Macaca fascicularis; Male; Mice; Nerve Tissue Proteins; Nucleic Acid Hybridization; Phosphoproteins; Rabbits; Rats; Rats, Inbred Strains; RNA, Messenger; Sodium-Potassium-Exchanging ATPase | 1989 |
Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Aldosterone; Blood Pressure; Dopamine; Dopamine Agents; Epoprostenol; Fenoldopam; Humans; Hypertension; Male; Middle Aged; Potassium; Reference Values; Renal Circulation; Renin; Sodium | 1989 |
Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Affinity Labels; Animals; Benzazepines; Binding, Competitive; Dopamine Agents; Dopamine Antagonists; Fenoldopam; Guanine Nucleotides; Hypertension; Kidney Tubules, Proximal; Male; Molecular Weight; Photochemistry; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine; Receptors, Dopamine D1 | 1989 |
Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cholinergic Fibers; Corpus Striatum; Drug Combinations; Ergolines; Fenoldopam; Male; Microinjections; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine; Stereotyped Behavior | 1989 |
Interaction study of fenoldopam--digoxin in congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Digoxin; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Female; Fenoldopam; Heart Failure; Humans; Male; Middle Aged | 1989 |
Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Dopamine Agents; Fenoldopam; Hemodynamics; In Vitro Techniques; Kidney Tubules; Male; Natriuresis; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1989 |
Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Dopamine Agents; Ergolines; Fenoldopam; Male; Methyltyrosines; Prolactin; Quinpirole; Rats; Rats, Inbred WKY | 1989 |
Effects of fenoldopam on cecal blood flow and mechanical activity in horses.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arteries; Blood Flow Velocity; Blood Pressure; Cecum; Colon; Dopamine Agents; Duodenum; Female; Fenoldopam; Gastrointestinal Motility; Heart Rate; Horses; Infusions, Intravenous; Male | 1989 |
The selective dopamine D1 receptor agonist SK&F 38393: its effects on palatability- and deprivation-induced feeding, and operant responding for food.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Drinking Behavior; Drug Interactions; Feeding Behavior; Fenoldopam; Food Deprivation; Male; Mice; Rats; Stereoisomerism; Tetrahydronaphthalenes; Thiophenes | 1989 |
Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Diuresis; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation; Fenoldopam; Humans; Kidney Failure, Chronic; Natriuresis | 1989 |
Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding, Competitive; Clopenthixol; Corpus Striatum; Female; Fenoldopam; Flupenthixol; Fluphenazine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1985 |
Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine Triphosphate; Animals; Benzazepines; Binding, Competitive; Corpus Striatum; Fenoldopam; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Kinetics; Lithium; Male; Membranes; Potassium; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium | 1986 |
Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Benzazepines; Dopamine; Fenoldopam; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Rabbits; Renal Circulation; Vasodilator Agents | 1986 |
Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamines; Animals; Benzazepines; Conditioning, Psychological; Dopamine Agents; Ergolines; Fenoldopam; Homing Behavior; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Taste | 1988 |
Human vasodilator responses to a dopamine agonist: possible mechanisms.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Forearm; Humans; Injections, Intra-Arterial; Male; Regional Blood Flow; Vasodilation | 1985 |
Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cattle; Corpus Striatum; Fenoldopam; Flupenthixol; Guanine Nucleotides; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1982 |
D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cerebral Cortex; Colforsin; Dopamine; Dopamine Agents; Epilepsy; Female; Fenoldopam; In Vitro Techniques; Magnesium; Male; Propranolol; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1993 |
Natriuretic effects of dopamine agonist drugs in models of reduced renal mass.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Animals; Blood Pressure; Diuresis; Dogs; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Heart Rate; Humans; Kidney Failure, Chronic; Lisuride; Middle Aged; Natriuresis; Norepinephrine; Renal Circulation; Sodium | 1993 |
Bidirectional regulation of Na+,K(+)-ATPase activity by dopamine and an alpha-adrenergic agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Calcimycin; Denervation; Dopamine; Dopamine Agents; Ethers, Cyclic; Fenoldopam; In Vitro Techniques; Kidney; Kidney Tubules; Kinetics; Male; Okadaic Acid; Oxymetazoline; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Potassium-Exchanging ATPase; Staurosporine; Tacrolimus | 1993 |
Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine; Dopamine Agonists; Drug Interactions; Electric Stimulation; Ergolines; Evoked Potentials; Fenoldopam; In Vitro Techniques; Male; Mesencephalon; Microelectrodes; Neostriatum; Neurons; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley | 1994 |
Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cocaine; Dopamine D2 Receptor Antagonists; Fenoldopam; Lidocaine; Male; Mice; Motor Activity; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Seizures; Structure-Activity Relationship | 1993 |
Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Cell Line; Chlorpromazine; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Epithelial Cells; Epithelium; Ergolines; Fenoldopam; Kidney; Levodopa; Phenothiazines; Quinpirole; Trifluoperazine | 1993 |
Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Angiotensin II; Animals; Bucladesine; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Electromagnetic Phenomena; Fenoldopam; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Rheology; Vasoconstriction; Vasodilator Agents | 1993 |
Effect of dietary protein on the renal response to fenoldopam in diabetic rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Diabetes Mellitus, Experimental; Dietary Proteins; Fenoldopam; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Renal Circulation; Vasodilator Agents | 1993 |
Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Chromans; Consciousness; Dogs; Dopamine Agents; Fenoldopam; Hemodynamics; Kidney; Male; Receptors, Dopamine D1 | 1994 |
The effect of dopamine on adenylate cyclase and Na+,K(+)-ATPase activity in the developing rat renal cortical and medullary tubule cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Age Factors; Animals; Colforsin; Cyclic AMP; Dopamine; Fenoldopam; Kidney Tubules, Proximal; Loop of Henle; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Sodium-Potassium-Exchanging ATPase | 1993 |
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Dopamine; Dopamine Agents; Ergolines; Esophagogastric Junction; Fenoldopam; In Vitro Techniques; Male; Peristalsis; Phentolamine; Prazosin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Fenoldopam; In Vitro Techniques; Lung; Perfusion; Pulmonary Circulation; Rabbits; Receptors, Dopamine D1; Vasodilation; Vasodilator Agents | 1994 |
Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Calcium; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Activation; Ergolines; Fenoldopam; Male; Phenethylamines; Protein Kinase C; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Synaptosomes; Tetrodotoxin | 1994 |
Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Brain Chemistry; Bucladesine; Carbachol; Colforsin; Corpus Striatum; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agents; Fenoldopam; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1994 |
Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Androstanes; Animals; Benzimidazoles; Biphenyl Compounds; Corpus Striatum; Fenoldopam; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Neurokinin-1 | 1994 |
Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic beta-Agonists; Animals; Blood Pressure; Dobutamine; Dopamine; Fenoldopam; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine; Superoxide Dismutase; Xanthine; Xanthine Oxidase; Xanthines | 1994 |
Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dogs; Dopamine Agents; Female; Fenoldopam; Fluorine; Kidney; Male; Rats; Rats, Inbred SHR; Receptors, Dopamine D1; Stereoisomerism; Structure-Activity Relationship; Vasodilator Agents | 1994 |
Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia, General; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Central Venous Pressure; Cerebrovascular Circulation; Dopamine Agents; Dose-Response Relationship, Drug; Female; Fenoldopam; Heart Rate; Hemodynamics; Hypercapnia; Hypertension; Intracranial Pressure; Intraocular Pressure; Male; Ocular Hypertension; Pseudotumor Cerebri; Pulmonary Wedge Pressure; Swine; Vascular Resistance | 1994 |
Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Blood Pressure; Cecum; Dopamine Agents; Female; Fenoldopam; Heart Rate; Hemodynamics; Horses; Male; Metoclopramide; Regional Blood Flow | 1993 |
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Brimonidine Tartrate; Calcium; Dopamine Agents; Ergolines; Fenoldopam; Humans; In Vitro Techniques; Indoles; Kidney Cortex; Middle Aged; Norepinephrine; Oxidopamine; Pyridines; Quinoxalines; Quinpirole; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1993 |
Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Benzazepines; Dopamine Agents; Fenoldopam; Hemodynamics; Pulmonary Circulation; Receptors, Dopamine; Sheep | 1993 |
Renal dopamine-1 receptors in hypertensive inbred rat strains with and without hyperactivity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Aging; Animals; Benzazepines; Blood Pressure; Colforsin; Dopamine Agents; Fenoldopam; Guanylyl Imidodiphosphate; Hypertension; Iodine Radioisotopes; Kidney; Kidney Cortex; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Kinetics; Male; Motor Activity; Nephrons; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Dopamine D1; Sodium | 1993 |
Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Centrifugation, Density Gradient; Dopamine; Dopamine Agents; Dopamine Antagonists; Fenoldopam; In Vitro Techniques; Indoles; Kidney Tubules, Proximal; Male; Nystatin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sodium-Potassium-Exchanging ATPase | 1993 |
Response to dopamine agonists of the rat isolated uterus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Catecholamines; Dopamine Agents; Ergolines; Female; Fenoldopam; In Vitro Techniques; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Reserpine; Serotonin; Uterine Contraction | 1993 |
Dopamine regulation of renal Na+,K(+)-ATPase activity is lacking in Dahl salt-sensitive rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bucladesine; Cyclic AMP; Dopamine; Dopamine Agents; Drug Resistance; Fenoldopam; Kidney; Kidney Tubules, Proximal; Loop of Henle; Male; Natriuresis; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Receptors, Dopamine; Reference Values; Sodium Chloride; Sodium-Potassium-Exchanging ATPase | 1993 |
cAMP-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Carrier Proteins; Cyclic AMP; Dopamine Agents; Fenoldopam; GTP-Binding Proteins; Kidney; Male; Microvilli; Protein Kinases; Rats; Rats, Inbred WKY; Receptors, Dopamine D1; Sodium; Sodium-Hydrogen Exchangers | 1993 |
The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alanine; Amino Acids; Animals; Dogs; Dopamine Agents; Drug Synergism; Female; Fenoldopam; Glomerular Filtration Rate; Hyperemia; Proline; Renal Circulation; Serine; Sodium | 1993 |
Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Biological Transport; Fenoldopam; Hypertension; Isoenzymes; Kidney Tubules; Norepinephrine; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine D1; Sodium-Potassium-Exchanging ATPase | 1998 |
Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
Topics: Animals; Cell Line; Chlorocebus aethiops; Computer Graphics; Dopamine; Dopamine Agonists; Glioma; Humans; Kinetics; Models, Molecular; Receptors, Dopamine D1; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Topics: Animals; Binding Sites; Databases, Factual; Dopamine Agonists; Humans; Ligands; Macaca mulatta; Models, Molecular; Molecular Conformation; Protein Structure, Secondary; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |